Home | All trials

[RDF data]
Trial NCT00000262

Resource URI: http://static.linkedct.org/resource/trials/NCT00000262
PropertyValue
linkedct:brief_title Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14
linkedct:collaborator_agency <http://static.linkedct.org/resource/collabagency/8705>
linkedct:condition <http://static.linkedct.org/resource/condition/12664>
linkedct:condition <http://static.linkedct.org/resource/condition/9249>
linkedct:criteria Please contact site for information.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age N/A
linkedct:eligibility_minimum_age N/A
linkedct:enrollment 0 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000262
rdfs:label Trial NCT00000262
linkedct:lastchanged_date June 23, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/193133>
linkedct:nct_id NCT00000262
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Effects of Combined Sevoflurane and Nitrous Oxide Inhalation
linkedct:org_study_id NIDA-08391-14
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/25443>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000262>
linkedct:phase Phase 2
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/13199>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/15141>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/17498>
linkedct:secondary_id R01-08391-14
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date November 1996
linkedct:study_design Treatment
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to determine the effects of combined sevoflurane and nitrous oxide inhalation on mood, psychomotor performance, and the pain response in humans.
rdf:type linkedct:trials
linkedct:verification_date November 1996